Yiqi-Huoxue Granule (YQHX) Downregulates Prothrombotic Factors by Modulating KLF2 and NF-<i>κ</i>B in HUVECs following LPS Stimulation
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Post-publication record
- Nature
- Retraction
- Reason
- Concerns/Issues about Data;Concerns/Issues about Results and/or Conclusions;Concerns/Issues about Referencing/Attributions;Concerns/Issues about Peer Review;Investigation by Journal/Publisher;Investigation by Third Party;Paper Mill;Computer-Aided Content or Computer-Generated Content;Unreliable Results and/or Conclusions;
- Date
- 1/9/2024 0:00
- Flagged by OpenAlex?
- Yes
Source: Retraction Watch, joined by DOI. OpenAlex records retraction as is_retracted, a boolean over a state space with at least four values, so it cannot express an expression of concern, a correction or a reinstatement — it reports them as false, which reads as “fine”.
Abstract
The Yiqi-Huoxue granule (YQHX) is a traditional Chinese medication widely used in the therapy of the traditional Chinese medicine diagnosis “Qi deficiency” or “blood stasis” in China. Both these symptoms are related to inflammation, but the mechanisms of YQHX against inflammation are largely unknown. Thus, our present study investigated the effects of YQHX on regulating inflammatory responses induced by lipopolysaccharides (LPS) in HUVECs. Our data found that YQHX remarkably inhibits the production of prothrombotic factors, plasminogen activator inhibitor-1 (PAI-1) and tissue factor (TF), while it upregulates the protein expression of Kruppel-like factor 2 (KLF2). The increase in PAI-1 and TF was significantly attenuated through a transgenic knockdown in KLF2 with a Lenti-shKLF2 vector. YQHX also decreases the phosphorylation of nuclear factor- κ B (NF- κ B) p65 and I κ B following LPS stimulation, and it effectively suppresses PAI-1 and TF via a NF- κ B-dependent mechanism. Taken together, our results suggest that YQHX provides a notable antithrombotic activity via regulating the KLF2 expression and NF- κ B signaling pathway in HUVECs. The KLF2 and NF- κ B may be potential therapeutic targets for interventions of inflammation associated with atherosclerosis.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Oxidative Medicine and Cellular Longevity
- Topic
- Kruppel-like factors research
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- Memorial University of Newfoundland
- Funders
- National Natural Science Foundation of China
- Keywords
- KLF2InflammationGene knockdownTissue factorNF-κBIκBαStimulationNFKB1Tissue factor pathway inhibitorActivator (genetics)Tissue plasminogen activatorSignal transductionPlasminogen activator inhibitor-1PharmacologyPlasminogen activatorCancer researchImmunologyChemistryCell biologyBiologyMedicineDownregulation and upregulationInternal medicineEndocrinologyApoptosisTranscription factorCoagulationBiochemistryReceptor
- Has abstract in OpenAlex
- yes